Tokyo, July 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062095) titled 'Prospective Observational Study of Resectable and Borderline Resectable Pancreatic Cancer' on July 20.
Study Type:
Observational
Primary Sponsor:
Institute - Kyoto University
Condition:
Condition - Pancreatic cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this prospective observational study is to enroll patients with resectable (R) and borderline resectable (BR) pancreatic cancer before treatment initiation and to collect real-world clinical data throughout neoadjuvant therapy, surgery, postoperative course, and long-term follow-up. The...